Literature DB >> 2413065

Sex hormone-binding globulin changes during the menstrual cycle.

S R Plymate, D E Moore, C Y Cheng, C W Bardin, M B Southworth, M J Levinski.   

Abstract

Although sex hormone-binding globulin (SHBG) production is stimulated by estrogen, no change in SHBG has been demonstrated during the menstrual cycle. To further study possible cyclic changes in serum SHBG, 12 women with a normal menstrual and fertility history had daily SHBG measurements during a menstrual cycle. SHBG was measured by dextran-coated charcoal saturation analysis and RIA. Serum LH was measured by mouse Leydig cell bioassay and RIA, and FSH, estradiol (E2), and progesterone were determined by RIA. In 10 women, a significant increase in mean SHBG by both methods occurred during the luteal phase of the cycle, immediately after the preovulatory increase in serum E2 (P less than 0.001). Two women had no SHBG increase; although each had a significant rise in serum E2 before the LH surge, luteal phase E2 levels were similar to those in the early follicular phase. In one of these women, a rise in SHBG was demonstrated by RIA. This study demonstrates that SHBG changes during the menstrual cycle in association with E2 changes, and it appears to be a marker for the endogenous estrogen changes that occur in normal ovulating women.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2413065     DOI: 10.1210/jcem-61-5-993

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

1.  Soy isoflavone supplementation for breast cancer risk reduction: a randomized phase II trial.

Authors:  Seema A Khan; Robert T Chatterton; Nancy Michel; Michelle Bryk; Oukseub Lee; David Ivancic; Richard Heinz; Carola M Zalles; Irene B Helenowski; Borko D Jovanovic; Adrian A Franke; Maarten C Bosland; Jun Wang; Nora M Hansen; Kevin P Bethke; Alexander Dew; Margerie Coomes; Raymond C Bergan
Journal:  Cancer Prev Res (Phila)       Date:  2012-02

2.  Serum and follicular fluid sex hormone-binding globulin in stimulated and unstimulated cycles.

Authors:  I Phocas; T Mantzavinos; A Sarandakou; F Dimitriadou; P A Zourlas
Journal:  J Assist Reprod Genet       Date:  1995-07       Impact factor: 3.412

3.  Associations of Serum Levels of Sex Hormones in Follicular and Luteal Phases of the Menstrual Cycle with Breast Tissue Characteristics in Young Women.

Authors:  Linda Linton; Monica Taylor; Sheila Dunn; Lisa Martin; Sonia Chavez; Greg Stanitz; Ella Huszti; Salomon Minkin; Norman Boyd
Journal:  PLoS One       Date:  2016-10-07       Impact factor: 3.240

4.  A phase 1, open-label study to evaluate the drug interaction between islatravir (MK-8591) and the oral contraceptive levonorgestrel/ethinyl estradiol in healthy adult females.

Authors:  Wendy Ankrom; Deanne Jackson Rudd; Saijuan Zhang; Kerry L Fillgrove; Kezia N Gravesande; Randolph P Matthews; Darin Brimhall; S Aubrey Stoch; Marian N Iwamoto
Journal:  J Int AIDS Soc       Date:  2021-12       Impact factor: 5.396

5.  Sex hormone binding globulin and risk factors for breast cancer in a population of normal women who had never used exogenous sex hormones.

Authors:  J W Moore; T J Key; R D Bulbrook; G M Clark; D S Allen; D Y Wang; M C Pike
Journal:  Br J Cancer       Date:  1987-11       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.